Evidence map›Paper›PMID 33665979›Full record

ArticleThe journal of pathology. Clinical research2021

The presence of tumour-infiltrating neutrophils is an independent adverse prognostic feature in clear cell renal cell carcinoma.

Basile Tessier-Cloutier, David Dw Twa, Mahsa Marzban, Jennifer Kalina, Hye-Jung E Chun, Nils Pavey, Zaidi Tanweer, Ruth L Katz, Julian J Lum, Davide Salina

Open access · goldAbstract read
In one paragraph

Article in The journal of pathology. Clinical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. The ratio of intratumoral CD15Cancer reports (Hoboken, N.J.) · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Basile Tessier-CloutierDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0001-8739-3879
David Dw TwaFaculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Mahsa MarzbanLife Science Institute, University of British Columbia, Vancouver, BC, Canada.
Jennifer KalinaThe Trev & Joyce Deeley Research Centre, BC Cancer, Victoria, BC, Canada.
Hye-Jung E ChunCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
Nils PaveyDepartment of Pathology and Laboratory Medicine, Royal Jubilee Hospital, Victoria, BC, Canada.
Zaidi TanweerDepartment of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
Ruth L KatzDepartment of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
Julian J LumThe Trev & Joyce Deeley Research Centre, BC Cancer, Victoria, BC, Canada.
Davide SalinaDepartment of Pathology and Laboratory Medicine, Royal Jubilee Hospital, Victoria, BC, Canada.
University of British Columbia · CARoyal Jubilee Hospital · CAThe University of Texas MD Anderson Cancer Center · USUniversity of Victoria · CACanada's Michael Smith Genome Sciences Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumour-promoting inflammation is an emerging hallmark of cancer that is increasingly recognised as a therapeutic target. As a constituent measure of inflammation, tumour-infiltrating neutrophils (TINs) have been associated with inferior prognosis in several cancers. We analysed clinically annotated cohorts of clear cell renal cell carcinoma (ccRCC) to assess the presence of neutrophils within the tumour microenvironment as a function of outcome. We centrally reviewed ccRCC surgical resection and fine-needle aspiration (FNA) specimens, including primary and metastatic sites, from three centres. TINs were scored based on the presence of neutrophils in resection and FNA specimens by two pathologists. TIN count was correlated with tumour characteristics including stage, WHO/ISUP grade, and immunohistochemistry (IHC). In parallel, we performed CIBERSORT analysis of the tumour microenvironment in a cohort of 516 ccRCCs from The Cancer Genome Atlas (TCGA). We included 102 ccRCC cases comprising 65 resection specimens (37 primary and 28 metastatic resection specimens) and 37 FNAs from primary lesions. High TINs were significantly associated with worse overall survival (p = 0.009) independent of tumour grade and stage. In ccRCCs sampled via FNA, all cases with high TINs had distant metastasis, whereas they were seen in only 19% of cases with low TINs (p = 0.0003). IHC analysis showed loss of E-cadherin in viable tumour cells in areas with high TINs, and neutrophil activation was associated with elastase and citrullinated histone H3 expression (cit-H3). In the TCGA cohort, neutrophilic markers were also associated with worse survival (p < 0.0001). TINs are an independent predictor of worse prognosis in ccRCC, which have the potential to be assessed at the time of first biopsy or FNA. Neutrophils act directly on tumour tissue by releasing elastase, a factor that contributes to the breakdown of cell-cell adhesion and to facilitate tumour dissemination.

Indexed as

NeutrophilsPrognosisAdultAgedAged, 80 and overBiomarkers, TumorBiopsy, Fine-NeedleCadherinsCarcinoma, Renal CellCohort StudiesFemaleHistonesHumansImmunohistochemistryKidney NeoplasmsMaleBiomarkers, TumorCadherinsHistonesPancreatic ElastaseCIBERSORTclear cell renal cell carcinomaimmunohistochemistrysurvival analysistumour-infiltrating neutrophils

Identifiers

PMID33665979
PMCPMC8185362
OpenAlexW3135501900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.